1. Home
  2. USAS vs PHAT Comparison

USAS vs PHAT Comparison

Compare USAS & PHAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • USAS
  • PHAT
  • Stock Information
  • Founded
  • USAS 1998
  • PHAT 2018
  • Country
  • USAS Canada
  • PHAT United States
  • Employees
  • USAS N/A
  • PHAT N/A
  • Industry
  • USAS Metal Mining
  • PHAT Biotechnology: Pharmaceutical Preparations
  • Sector
  • USAS Basic Materials
  • PHAT Health Care
  • Exchange
  • USAS Nasdaq
  • PHAT Nasdaq
  • Market Cap
  • USAS 1.1B
  • PHAT 942.6M
  • IPO Year
  • USAS N/A
  • PHAT 2019
  • Fundamental
  • Price
  • USAS $3.65
  • PHAT $14.98
  • Analyst Decision
  • USAS Strong Buy
  • PHAT Strong Buy
  • Analyst Count
  • USAS 2
  • PHAT 5
  • Target Price
  • USAS $4.08
  • PHAT $17.60
  • AVG Volume (30 Days)
  • USAS 3.1M
  • PHAT 987.8K
  • Earning Date
  • USAS 11-10-2025
  • PHAT 10-30-2025
  • Dividend Yield
  • USAS N/A
  • PHAT N/A
  • EPS Growth
  • USAS N/A
  • PHAT N/A
  • EPS
  • USAS N/A
  • PHAT N/A
  • Revenue
  • USAS $104,867,000.00
  • PHAT $147,190,000.00
  • Revenue This Year
  • USAS $26.26
  • PHAT $218.38
  • Revenue Next Year
  • USAS $67.48
  • PHAT $87.14
  • P/E Ratio
  • USAS N/A
  • PHAT N/A
  • Revenue Growth
  • USAS N/A
  • PHAT 460.30
  • 52 Week Low
  • USAS $0.87
  • PHAT $2.21
  • 52 Week High
  • USAS $5.12
  • PHAT $16.08
  • Technical
  • Relative Strength Index (RSI)
  • USAS 43.99
  • PHAT 62.68
  • Support Level
  • USAS $3.64
  • PHAT $14.12
  • Resistance Level
  • USAS $4.04
  • PHAT $15.41
  • Average True Range (ATR)
  • USAS 0.28
  • PHAT 0.90
  • MACD
  • USAS -0.07
  • PHAT 0.03
  • Stochastic Oscillator
  • USAS 12.39
  • PHAT 85.32

About USAS Americas Gold and Silver Corporation no par value

Americas Gold And Silver Corp is a mining company engaged in the acquisition, exploration, development, and production of precious metals mineral properties in Mexico and the United States. The company's primary operating assets, which are also its reporting segments, are the Cosala operations, the Galena Complex, and Relief Canyon. It also holds interests in the San Felipe Development Project located in Sonora, Mexico. The Cosala operations segment, which derives maximum revenue, operates in Mexico, while the Galena Complex and Relief Canyon segments operate in the United States.

About PHAT Phathom Pharmaceuticals Inc.

Phathom Pharmaceuticals Inc operates as a clinical-stage biopharmaceutical company. The firm is focused on developing and commercializing novel treatments for gastrointestinal, or GI, diseases. Its product comprises vonoprazan, an oral small-molecule potassium competitive acid blocker medicine that blocks acid secretion in the stomach. Vonoprazan shows rapid, potent, and durable anti-secretory effects and has demonstrated clinical benefits in the treatment of gastroesophageal reflux disease, and in combination with antibiotics for the treatment of Helicobacter pylori infection.

Share on Social Networks: